Clinical Trial Update: Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating olaparib in combination with carboplatin and paclitaxel versus carboplatin and paclitaxel in advanced ovarian cancer; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2012-12-10